Albert Do

617 total citations
33 papers, 385 citations indexed

About

Albert Do is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Albert Do has authored 33 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 19 papers in Hepatology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Albert Do's work include Liver Disease Diagnosis and Treatment (20 papers), Hepatitis C virus research (9 papers) and Liver Disease and Transplantation (7 papers). Albert Do is often cited by papers focused on Liver Disease Diagnosis and Treatment (20 papers), Hepatitis C virus research (9 papers) and Liver Disease and Transplantation (7 papers). Albert Do collaborates with scholars based in United States, Australia and United Kingdom. Albert Do's co-authors include Joseph K. Lim, Janice Weinberg, Brian C. Jacobson, Wajahat Z. Mehal, Nancy Reau, Bubu A. Banini, AnnMarie Liapakis, Ramsey Cheung, Maria Ciarleglio and Claudia A. Bertuccio and has published in prestigious journals such as Nucleic Acids Research, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Albert Do

31 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Do United States 12 208 142 81 73 59 33 385
Guy Lampe Australia 11 226 1.1× 154 1.1× 44 0.5× 48 0.7× 38 0.6× 25 395
Yukihisa Fujinaga Japan 14 202 1.0× 139 1.0× 62 0.8× 43 0.6× 68 1.2× 46 418
Pimsiri Sripongpun Thailand 12 319 1.5× 251 1.8× 43 0.5× 31 0.4× 53 0.9× 65 446
Ken Nishino Japan 10 314 1.5× 239 1.7× 27 0.3× 25 0.3× 56 0.9× 37 433
Faruk Memik Türkiye 10 188 0.9× 67 0.5× 87 1.1× 58 0.8× 96 1.6× 23 383
И. Г. Бакулин Russia 10 223 1.1× 136 1.0× 26 0.3× 45 0.6× 34 0.6× 124 472
Sanjay Ramrakhiani United States 8 155 0.7× 110 0.8× 102 1.3× 81 1.1× 51 0.9× 21 309
Thinesh Lee Krishnamoorthy Singapore 9 151 0.7× 154 1.1× 44 0.5× 23 0.3× 17 0.3× 25 375
Mónica Marino Italy 10 172 0.8× 169 1.2× 23 0.3× 40 0.5× 54 0.9× 23 322
K. Shiva Kumar United States 10 328 1.6× 177 1.2× 31 0.4× 24 0.3× 134 2.3× 23 460

Countries citing papers authored by Albert Do

Since Specialization
Citations

This map shows the geographic impact of Albert Do's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Do with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Do more than expected).

Fields of papers citing papers by Albert Do

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Do. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Do. The network helps show where Albert Do may publish in the future.

Co-authorship network of co-authors of Albert Do

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Do. A scholar is included among the top collaborators of Albert Do based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Do. Albert Do is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Do, Albert, et al.. (2024). Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH). Nature Reviews Drug Discovery. 24(3). 171–189. 33 indexed citations
2.
Wong, Robert J., et al.. (2024). Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among US Veterans With Steatotic Liver Disease. Gastroenterology. 166(6). 1156–1165.e4. 14 indexed citations
4.
Cheung, Ramsey, et al.. (2023). Cardiovascular Disease Risk and Statin Use Among Adults with Metabolic Dysfunction Associated Fatty Liver Disease. The American Journal of Medicine. 136(7). 669–676.e1. 5 indexed citations
5.
Banini, Bubu A., et al.. (2023). Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice. Current Gastroenterology Reports. 25(10). 213–224. 19 indexed citations
6.
Do, Albert, et al.. (2022). Increased Mortality in Patients Undergoing Inpatient Endoscopy During the Early COVID-19 Pandemic. Digestive Diseases and Sciences. 67(11). 5053–5062. 3 indexed citations
7.
Schwartz, Andrew, et al.. (2022). S1453 Weight Loss in Bariatric Surgery Patients Treated at a Novel Clinic Incorporating Obesity Medicine for Treatment of Nonalcoholic Fatty Liver Disease. The American Journal of Gastroenterology. 117(10S). e1043–e1044. 1 indexed citations
8.
Banini, Bubu A., et al.. (2022). The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review. Clinical and Molecular Hepatology. 29(Suppl). S319–S332. 7 indexed citations
9.
Do, Albert, et al.. (2022). Clinical Phenotyping and the Application of Precision Medicine in MAFLD. Clinical Liver Disease. 19(6). 227–233. 5 indexed citations
10.
Do, Albert, Denise Esserman, Supriya Krishnan, et al.. (2020). Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals. Journal of General Internal Medicine. 35(7). 2025–2034. 22 indexed citations
11.
Do, Albert, Denise Esserman, Supriya Krishnan, et al.. (2020). Correction to: Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals. Journal of General Internal Medicine. 35(10). 3140–3140. 2 indexed citations
12.
Muniraj, Thiruvengadam, et al.. (2020). Endoscopic Retrograde Cholangiopancreatography: Deciphering the Black and White. Current Problems in Diagnostic Radiology. 50(1). 74–84. 2 indexed citations
13.
Do, Albert & Nancy Reau. (2020). Chronic Viral Hepatitis: Current Management and Future Directions. Hepatology Communications. 4(3). 329–341. 27 indexed citations
15.
Do, Albert, et al.. (2019). IMPACT OF DRUG ABUSE IN ACUTE CORONARY SYNDROME: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2012-2015. Journal of the American College of Cardiology. 73(9). 163–163. 1 indexed citations
16.
17.
Tak, Yu Gyoung, Lijing Yao, Matthew Grimmer, et al.. (2016). Effects on the transcriptome upon deletion of a distal element cannot be predicted by the size of the H3K27Ac peak in human cells. Nucleic Acids Research. 44(9). 4123–4133. 27 indexed citations
18.
Njei, Basile, Albert Do, Thomas R. McCarty, & Brett E. Fortune. (2016). Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis. Journal of Clinical Gastroenterology. 50(10). 871–881. 4 indexed citations
19.
Do, Albert, Yash Mittal, AnnMarie Liapakis, et al.. (2015). Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade. PLoS ONE. 10(8). e0135645–e0135645. 52 indexed citations
20.
Do, Albert, et al.. (2012). Reliability of adenoma detection rate is based on procedural volume. Gastrointestinal Endoscopy. 77(3). 376–380. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026